Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. CREDIT AGREEMENT dated...Credit Agreement • February 21st, 2023 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New York
This CREDIT AGREEMENT is entered into as of October 27, 2022, among PTC THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), the Guarantors (as defined herein) from time to time party hereto, the Lenders (as defined herein) from time to time party hereto and Wilmington Trust, National Association, as Administrative Agent (as defined herein).
PTC Therapeutics, Inc. Restricted Stock Unit AgreementRestricted Stock Unit Agreement • February 21st, 2023 • PTC Therapeutics, Inc. • Pharmaceutical preparations • Delaware
PTC Therapeutics, Inc. (the “Company”) hereby grants the following restricted stock units pursuant to its Amended and Restated 2013 Long-Term Incentive Plan. The terms and conditions attached hereto are also a part hereof.
PTC Therapeutics, Inc. Incentive Stock Option Agreement Granted Under Amended and Restated 2013 Long-Term Incentive PlanIncentive Stock Option Agreement • February 21st, 2023 • PTC Therapeutics, Inc. • Pharmaceutical preparations
This agreement evidences the grant by PTC Therapeutics, Inc., a Delaware corporation (the “Company”), on [Grant Date] (the “Grant Date”) to [Participant Name], an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s Amended and Restated 2013 Long-Term Incentive Plan (the “Plan”), a total of [Number of Awards Granted] shares (the “Shares”) of common stock, $0.001 par value per share, of the Company (“Common Stock”) at $[Grant Price] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [Expiration Date] (the “Final Exercise Date”).
PTC Therapeutics, Inc. Nonstatutory Stock Option Agreement Granted Under Amended and Restated 2013 Long-Term Incentive PlanNonstatutory Stock Option Agreement • February 21st, 2023 • PTC Therapeutics, Inc. • Pharmaceutical preparations
This agreement evidences the grant by PTC Therapeutics, Inc., a Delaware corporation (the “Company”), on [Grant Date] (the “Grant Date”) to [Participant Name], an employee, consultant or advisor of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s Amended and Restated 2013 Long-Term Incentive Plan (the “Plan”), a total of [Number of Awards Granted] shares (the “Shares”) of common stock, $0.001 par value per share, of the Company (“Common Stock”) at $[ Grant Price ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [Expiration Date] (the “Final Exercise Date”).
STOCK PURCHASE AGREEMENT BY AND AMONG THE INVESTORS LISTED HEREIN AND PTC THERAPEUTICS, INC. DATED AS OF OCTOBER 27, 2022Stock Purchase Agreement • February 21st, 2023 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New York
Nonstatutory Stock Option Agreement Granted Under Amended and RestatedNonstatutory Stock Option Agreement • February 21st, 2023 • PTC Therapeutics, Inc. • Pharmaceutical preparations
This Agreement evidences the grant by PTC Therapeutics, Inc., a Delaware corporation (the “Company”), on [Grant Date] (the “Grant Date”) to [Participant Name] a director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s Amended and Restated 2013 Long-Term Incentive Plan (the “Plan”), a total of [Number of Awards Granted] shares (the “Shares”) of common stock, $0.001 par value per share, of the Company (“Common Stock”) at [Grant Price] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [Expiration Date] (the “Final Exercise Date”).
